APO Research
Talk to an analyst

APO RESEARCH · REPORT

Fast-Acting Insulin Analog

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Fast-Acting Insulin Analog Industry Growth and Trends Forecast to 2032

29 December 202594 pages

Choose your research edition.

Industry ResearchFast-Acting Insulin Analog Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Fast-Acting Insulin Analog Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Fast-Acting Insulin Analog Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fast-Acting Insulin Analog Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Fast-Acting Insulin Analog Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Fast-Acting Insulin Analog market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Fast-Acting Insulin Analog is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Fast-Acting Insulin Analog is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Fast-Acting Insulin Analog is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Fast-Acting Insulin Analog include Tonghua Dongbao Pharmaceutical, Sanofi, Novo Nordisk, The United Laboratories International Holdings, Eli Lilly and Company and Gan and Lee Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Fast-Acting Insulin Analog market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Fast-Acting Insulin Analog market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Fast-Acting Insulin Analog market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Fast-Acting Insulin Analog.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Fast-Acting Insulin Analog market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Fast-Acting Insulin Analog Market by Company

Tonghua Dongbao Pharmaceutical

Sanofi

Novo Nordisk

The United Laboratories International Holdings

Eli Lilly and Company

Gan and Lee Pharmaceuticals

Fast-Acting Insulin Analog Segment by Type

Insulin Aspart

Insulin Lispro

Insulin Glulisine

Fast-Acting Insulin Analog Segment by Application

Gestational Diabetes

Type 2 Diabetes

Type 1 Diabetes

Other Diabetes

Fast-Acting Insulin Analog Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fast-Acting Insulin Analog market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fast-Acting Insulin Analog and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fast-Acting Insulin Analog.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Fast-Acting Insulin Analog manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Fast-Acting Insulin Analog in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Insulin Aspart Table 2. Major Company of Insulin Lispro Table 3. Major Company of Insulin Glulisine Table 4. Global Fast-Acting Insulin Analog Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Fast-Acting Insulin Analog Sales by Type (2021-2026) & (K Units) Table 6. Global Fast-Acting Insulin Analog Sales Market Share in Volume by Type (2021-2026) Table 7. Global Fast-Acting Insulin Analog Sales by Type (2021-2026) & (US$ Million) Table 8. Global Fast-Acting Insulin Analog Sales Market Share in Value by Type (2021-2026) Table 9. Global Fast-Acting Insulin Analog Price by Type (2021-2026) & (US$/Unit) Table 10. Global Fast-Acting Insulin Analog Sales by Type (2027-2032) & (K Units) Table 11. Global Fast-Acting Insulin Analog Sales Market Share in Volume by Type (2027-2032) Table 12. Global Fast-Acting Insulin Analog Sales by Type (2027-2032) & (US$ Million) Table 13. Global Fast-Acting Insulin Analog Sales Market Share in Value by Type (2027-2032) Table 14. Global Fast-Acting Insulin Analog Price by Type (2027-2032) & (US$/Unit) Table 15. North America Fast-Acting Insulin Analog Sales by Type (2021-2026) & (K Units) Table 16. North America Fast-Acting Insulin Analog Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Fast-Acting Insulin Analog Sales by Type (2021-2026) & (K Units) Table 18. Europe Fast-Acting Insulin Analog Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Fast-Acting Insulin Analog Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Fast-Acting Insulin Analog Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Fast-Acting Insulin Analog Sales by Type (2021-2026) & (K Units) Table 22. Latin America Fast-Acting Insulin Analog Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Fast-Acting Insulin Analog Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Fast-Acting Insulin Analog Sales by Type (2021-2026) & (US$ Million) Table 25. Fast-Acting Insulin Analog Industry Trends Table 26. Fast-Acting Insulin Analog Industry Drivers Table 27. Fast-Acting Insulin Analog Industry Opportunities and Challenges Table 28. Fast-Acting Insulin Analog Industry Restraints Table 29. Global Fast-Acting Insulin Analog Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Fast-Acting Insulin Analog Revenue Market Share by Company (2021-2026) Table 31. Global Fast-Acting Insulin Analog Sales by Company (2021-2026) & (K Units) Table 32. Global Fast-Acting Insulin Analog Sales Share by Company (2021-2026) Table 33. Global Fast-Acting Insulin Analog Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Fast-Acting Insulin Analog Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Fast-Acting Insulin Analog Major Company Production Sites and Headquarters Table 36. Global Fast-Acting Insulin Analog Company, Product Type & Application Table 37. Global Fast-Acting Insulin Analog Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Fast-Acting Insulin Analog by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Fast-Acting Insulin Analog Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Fast-Acting Insulin Analog Sales by Region (2021-2026) & (K Units) Table 42. Global Fast-Acting Insulin Analog Sales Market Share in Volume by Region (2021-2026) Table 43. Global Fast-Acting Insulin Analog Sales by Region (2021-2026) & (US$ Million) Table 44. Global Fast-Acting Insulin Analog Sales Market Share in Value by Region (2021-2026) Table 45. Global Fast-Acting Insulin Analog Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Fast-Acting Insulin Analog Sales by Region (2027-2032) & (K Units) Table 47. Global Fast-Acting Insulin Analog Sales Market Share in Volume by Region (2027-2032) Table 48. Global Fast-Acting Insulin Analog Sales by Region (2027-2032) & (US$ Million) Table 49. Global Fast-Acting Insulin Analog Sales Market Share in Value by Region (2027-2032) Table 50. Global Fast-Acting Insulin Analog Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Fast-Acting Insulin Analog Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Fast-Acting Insulin Analog Sales by Application (2021-2026) & (K Units) Table 53. Global Fast-Acting Insulin Analog Sales Market Share in Volume by Application (2021-2026) Table 54. Global Fast-Acting Insulin Analog Sales by Application (2021-2026) & (US$ Million) Table 55. Global Fast-Acting Insulin Analog Sales Market Share in Value by Application (2021-2026) Table 56. Global Fast-Acting Insulin Analog Price by Application (2021-2026) & (US$/Unit) Table 57. Global Fast-Acting Insulin Analog Sales by Application (2027-2032) & (K Units) Table 58. Global Fast-Acting Insulin Analog Sales Market Share in Volume by Application (2027-2032) Table 59. Global Fast-Acting Insulin Analog Sales by Application (2027-2032) & (US$ Million) Table 60. Global Fast-Acting Insulin Analog Sales Market Share in Value by Application (2027-2032) Table 61. Global Fast-Acting Insulin Analog Price by Application (2027-2032) & (US$/Unit) Table 62. North America Fast-Acting Insulin Analog Sales by Application (2021-2026) & (K Units) Table 63. North America Fast-Acting Insulin Analog Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Fast-Acting Insulin Analog Sales by Application (2021-2026) & (K Units) Table 65. Europe Fast-Acting Insulin Analog Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Fast-Acting Insulin Analog Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Fast-Acting Insulin Analog Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Fast-Acting Insulin Analog Sales by Application (2021-2026) & (K Units) Table 69. Latin America Fast-Acting Insulin Analog Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Fast-Acting Insulin Analog Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Fast-Acting Insulin Analog Sales by Application (2021-2026) & (US$ Million) Table 72. Tonghua Dongbao Pharmaceutical Company Information Table 73. Tonghua Dongbao Pharmaceutical Business Overview Table 74. Tonghua Dongbao Pharmaceutical Fast-Acting Insulin Analog Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Tonghua Dongbao Pharmaceutical Fast-Acting Insulin Analog Product Portfolio Table 76. Tonghua Dongbao Pharmaceutical Recent Development Table 77. Sanofi Company Information Table 78. Sanofi Business Overview Table 79. Sanofi Fast-Acting Insulin Analog Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Sanofi Fast-Acting Insulin Analog Product Portfolio Table 81. Sanofi Recent Development Table 82. Novo Nordisk Company Information Table 83. Novo Nordisk Business Overview Table 84. Novo Nordisk Fast-Acting Insulin Analog Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Novo Nordisk Fast-Acting Insulin Analog Product Portfolio Table 86. Novo Nordisk Recent Development Table 87. The United Laboratories International Holdings Company Information Table 88. The United Laboratories International Holdings Business Overview Table 89. The United Laboratories International Holdings Fast-Acting Insulin Analog Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. The United Laboratories International Holdings Fast-Acting Insulin Analog Product Portfolio Table 91. The United Laboratories International Holdings Recent Development Table 92. Eli Lilly and Company Company Information Table 93. Eli Lilly and Company Business Overview Table 94. Eli Lilly and Company Fast-Acting Insulin Analog Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Eli Lilly and Company Fast-Acting Insulin Analog Product Portfolio Table 96. Eli Lilly and Company Recent Development Table 97. Gan and Lee Pharmaceuticals Company Information Table 98. Gan and Lee Pharmaceuticals Business Overview Table 99. Gan and Lee Pharmaceuticals Fast-Acting Insulin Analog Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Gan and Lee Pharmaceuticals Fast-Acting Insulin Analog Product Portfolio Table 101. Gan and Lee Pharmaceuticals Recent Development Table 102. North America Fast-Acting Insulin Analog Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 103. North America Fast-Acting Insulin Analog Sales by Country (2021-2026) & (K Units) Table 104. North America Fast-Acting Insulin Analog Sales Market Share by Country (2021-2026) Table 105. North America Fast-Acting Insulin Analog Sales Forecast by Country (2027-2032) & (K Units) Table 106. North America Fast-Acting Insulin Analog Sales Market Share Forecast by Country (2027-2032) Table 107. North America Fast-Acting Insulin Analog Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. North America Fast-Acting Insulin Analog Market Size by Country (2021-2026) & (US$ Million) Table 109. North America Fast-Acting Insulin Analog Market Share by Country (2021-2026) Table 110. North America Fast-Acting Insulin Analog Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. North America Fast-Acting Insulin Analog Market Share Forecast by Country (2027-2032) Table 112. Europe Fast-Acting Insulin Analog Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. Europe Fast-Acting Insulin Analog Sales by Country (2021-2026) & (K Units) Table 114. Europe Fast-Acting Insulin Analog Sales Market Share by Country (2021-2026) Table 115. Europe Fast-Acting Insulin Analog Sales Forecast by Country (2027-2032) & (K Units) Table 116. Europe Fast-Acting Insulin Analog Sales Market Share Forecast by Country (2027-2032) Table 117. Europe Fast-Acting Insulin Analog Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Europe Fast-Acting Insulin Analog Market Size by Country (2021-2026) & (US$ Million) Table 119. Europe Fast-Acting Insulin Analog Market Share by Country (2021-2026) Table 120. Europe Fast-Acting Insulin Analog Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Europe Fast-Acting Insulin Analog Market Share Forecast by Country (2027-2032) Table 122. Asia-Pacific Fast-Acting Insulin Analog Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Asia-Pacific Fast-Acting Insulin Analog Sales by Country (2021-2026) & (K Units) Table 124. Asia-Pacific Fast-Acting Insulin Analog Sales Market Share by Country (2021-2026) Table 125. Asia-Pacific Fast-Acting Insulin Analog Sales Forecast by Country (2027-2032) & (K Units) Table 126. Asia-Pacific Fast-Acting Insulin Analog Sales Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific Fast-Acting Insulin Analog Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific Fast-Acting Insulin Analog Market Size by Country (2021-2026) & (US$ Million) Table 129. Asia-Pacific Fast-Acting Insulin Analog Market Share by Country (2021-2026) Table 130. Asia-Pacific Fast-Acting Insulin Analog Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Asia-Pacific Fast-Acting Insulin Analog Market Share Forecast by Country (2027-2032) Table 132. Latin America Fast-Acting Insulin Analog Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Latin America Fast-Acting Insulin Analog Sales by Country (2021-2026) & (K Units) Table 134. Latin America Fast-Acting Insulin Analog Sales Market Share by Country (2021-2026) Table 135. Latin America Fast-Acting Insulin Analog Sales Forecast by Country (2027-2032) & (K Units) Table 136. Latin America Fast-Acting Insulin Analog Sales Market Share Forecast by Country (2027-2032) Table 137. Latin America Fast-Acting Insulin Analog Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Latin America Fast-Acting Insulin Analog Market Size by Country (2021-2026) & (US$ Million) Table 139. Latin America Fast-Acting Insulin Analog Market Share by Country (2021-2026) Table 140. Latin America Fast-Acting Insulin Analog Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Latin America Fast-Acting Insulin Analog Market Share Forecast by Country (2027-2032) Table 142. Middle East and Africa Fast-Acting Insulin Analog Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Middle East and Africa Fast-Acting Insulin Analog Sales by Country (2021-2026) & (K Units) Table 144. Middle East and Africa Fast-Acting Insulin Analog Sales Market Share by Country (2021-2026) Table 145. Middle East and Africa Fast-Acting Insulin Analog Sales Forecast by Country (2027-2032) & (K Units) Table 146. Middle East and Africa Fast-Acting Insulin Analog Sales Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa Fast-Acting Insulin Analog Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa Fast-Acting Insulin Analog Market Size by Country (2021-2026) & (US$ Million) Table 149. Middle East and Africa Fast-Acting Insulin Analog Market Share by Country (2021-2026) Table 150. Middle East and Africa Fast-Acting Insulin Analog Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Middle East and Africa Fast-Acting Insulin Analog Market Share Forecast by Country (2027-2032) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Fast-Acting Insulin Analog Distributors List Table 155. Fast-Acting Insulin Analog Customers List Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Fast-Acting Insulin Analog Image Figure 2. Global Fast-Acting Insulin Analog Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fast-Acting Insulin Analog Market Size (2021-2032) & (US$ Million) Figure 4. Global Fast-Acting Insulin Analog Sales (2021-2032) & (K Units) Figure 5. Insulin Aspart Image Figure 6. Global Insulin Aspart Sales YoY Growth (2021-2032) & (K Units) Figure 7. Insulin Lispro Image Figure 8. Global Insulin Lispro Sales YoY Growth (2021-2032) & (K Units) Figure 9. Insulin Glulisine Image Figure 10. Global Insulin Glulisine Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Fast-Acting Insulin Analog Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Fast-Acting Insulin Analog Market Share by Type 2025 VS 2032 Figure 13. North America Fast-Acting Insulin Analog Sales Market Share in Volume by Type in 2025 Figure 14. North America Fast-Acting Insulin Analog Sales Market Share in Value by Type in 2025 Figure 15. Europe Fast-Acting Insulin Analog Sales Market Share in Volume by Type in 2025 Figure 16. Europe Fast-Acting Insulin Analog Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Fast-Acting Insulin Analog Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Fast-Acting Insulin Analog Sales Market Share in Value by Type in 2025 Figure 19. Latin America Fast-Acting Insulin Analog Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Fast-Acting Insulin Analog Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Fast-Acting Insulin Analog Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Fast-Acting Insulin Analog Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Fast-Acting Insulin Analog Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Gestational Diabetes Image Figure 26. Global Gestational Diabetes Sales YoY Growth (2021-2032) & (K Units) Figure 27. Type 2 Diabetes Image Figure 28. Global Type 2 Diabetes Sales YoY Growth (2021-2032) & (K Units) Figure 29. Type 1 Diabetes Image Figure 30. Global Type 1 Diabetes Sales YoY Growth (2021-2032) & (K Units) Figure 31. Other Diabetes Image Figure 32. Global Other Diabetes Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Fast-Acting Insulin Analog Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Fast-Acting Insulin Analog Market Share by Application 2025 VS 2032 Figure 35. North America Fast-Acting Insulin Analog Sales Market Share in Volume by Application in 2025 Figure 36. North America Fast-Acting Insulin Analog Sales Market Share in Value by Application in 2025 Figure 37. Europe Fast-Acting Insulin Analog Sales Market Share in Volume by Application in 2025 Figure 38. Europe Fast-Acting Insulin Analog Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Fast-Acting Insulin Analog Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Fast-Acting Insulin Analog Sales Market Share in Value by Application in 2025 Figure 41. Latin America Fast-Acting Insulin Analog Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Fast-Acting Insulin Analog Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Fast-Acting Insulin Analog Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Fast-Acting Insulin Analog Sales Market Share in Value by Application in 2025 Figure 45. North America Fast-Acting Insulin Analog Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Fast-Acting Insulin Analog Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Fast-Acting Insulin Analog Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Fast-Acting Insulin Analog Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Fast-Acting Insulin Analog Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Fast-Acting Insulin Analog Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Fast-Acting Insulin Analog Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Fast-Acting Insulin Analog Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Fast-Acting Insulin Analog Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Fast-Acting Insulin Analog Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Fast-Acting Insulin Analog Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Fast-Acting Insulin Analog Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Fast-Acting Insulin Analog Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Fast-Acting Insulin Analog Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Fast-Acting Insulin Analog Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Fast-Acting Insulin Analog Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Fast-Acting Insulin Analog Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Fast-Acting Insulin Analog Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Fast-Acting Insulin Analog Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Fast-Acting Insulin Analog Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Fast-Acting Insulin Analog Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Fast-Acting Insulin Analog Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Insulin Aspart
  • Insulin Lispro
  • Insulin Glulisine
Applications
  • Gestational Diabetes
  • Type 2 Diabetes
  • Type 1 Diabetes
  • Other Diabetes
Companies covered
  • Tonghua Dongbao Pharmaceutical
  • Sanofi
  • Novo Nordisk
  • The United Laboratories International Holdings
  • Eli Lilly and Company
  • Gan and Lee Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Fast-Acting Insulin Analog Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Fast-Acting Insulin Analog Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Fast-Acting Insulin Analog Market by Type
  6. 1.3.1 Insulin Aspart
  7. 1.3.2 Insulin Lispro
  8. 1.3.3 Insulin Glulisine
  9. 1.4 Global Fast-Acting Insulin Analog Market Size by Type
  10. 1.4.1 Global Fast-Acting Insulin Analog Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Fast-Acting Insulin Analog Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Fast-Acting Insulin Analog Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Fast-Acting Insulin Analog Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Fast-Acting Insulin Analog Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Fast-Acting Insulin Analog Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Fast-Acting Insulin Analog Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Fast-Acting Insulin Analog Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Fast-Acting Insulin Analog Industry Trends
  2. 2.2 Fast-Acting Insulin Analog Industry Drivers
  3. 2.3 Fast-Acting Insulin Analog Industry Opportunities and Challenges
  4. 2.4 Fast-Acting Insulin Analog Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Fast-Acting Insulin Analog Revenue (2021-2026)
  2. 3.2 Global Top Players by Fast-Acting Insulin Analog Sales (2021-2026)
  3. 3.3 Global Top Players by Fast-Acting Insulin Analog Price (2021-2026)
  4. 3.4 Global Fast-Acting Insulin Analog Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Fast-Acting Insulin Analog Major Company Production Sites & Headquarters
  6. 3.6 Global Fast-Acting Insulin Analog Company, Product Type & Application
  7. 3.7 Global Fast-Acting Insulin Analog Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Fast-Acting Insulin Analog Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Fast-Acting Insulin Analog Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Fast-Acting Insulin Analog Tier 1, Tier 2, and Tier 3
4 Fast-Acting Insulin Analog Regional Status and Outlook
  1. 4.1 Global Fast-Acting Insulin Analog Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Fast-Acting Insulin Analog Historic Market Size by Region
  3. 4.2.1 Global Fast-Acting Insulin Analog Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Fast-Acting Insulin Analog Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Fast-Acting Insulin Analog Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Fast-Acting Insulin Analog Forecasted Market Size by Region
  7. 4.3.1 Global Fast-Acting Insulin Analog Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Fast-Acting Insulin Analog Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Fast-Acting Insulin Analog Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Fast-Acting Insulin Analog by Application
  1. 5.1 Fast-Acting Insulin Analog Market by Application
  2. 5.1.1 Gestational Diabetes
  3. 5.1.2 Type 2 Diabetes
  4. 5.1.3 Type 1 Diabetes
  5. 5.1.4 Other Diabetes
  6. 5.2 Global Fast-Acting Insulin Analog Market Size by Application
  7. 5.2.1 Global Fast-Acting Insulin Analog Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Fast-Acting Insulin Analog Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Fast-Acting Insulin Analog Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Fast-Acting Insulin Analog Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Fast-Acting Insulin Analog Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Fast-Acting Insulin Analog Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Fast-Acting Insulin Analog Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Fast-Acting Insulin Analog Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Tonghua Dongbao Pharmaceutical
  2. 6.1.1 Tonghua Dongbao Pharmaceutical Company Information
  3. 6.1.2 Tonghua Dongbao Pharmaceutical Business Overview
  4. 6.1.3 Tonghua Dongbao Pharmaceutical Fast-Acting Insulin Analog Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Tonghua Dongbao Pharmaceutical Fast-Acting Insulin Analog Product Portfolio
  6. 6.1.5 Tonghua Dongbao Pharmaceutical Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Fast-Acting Insulin Analog Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Fast-Acting Insulin Analog Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Novo Nordisk
  14. 6.3.1 Novo Nordisk Company Information
  15. 6.3.2 Novo Nordisk Business Overview
  16. 6.3.3 Novo Nordisk Fast-Acting Insulin Analog Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novo Nordisk Fast-Acting Insulin Analog Product Portfolio
  18. 6.3.5 Novo Nordisk Recent Developments
  19. 6.4 The United Laboratories International Holdings
  20. 6.4.1 The United Laboratories International Holdings Company Information
  21. 6.4.2 The United Laboratories International Holdings Business Overview
  22. 6.4.3 The United Laboratories International Holdings Fast-Acting Insulin Analog Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 The United Laboratories International Holdings Fast-Acting Insulin Analog Product Portfolio
  24. 6.4.5 The United Laboratories International Holdings Recent Developments
  25. 6.5 Eli Lilly and Company
  26. 6.5.1 Eli Lilly and Company Company Information
  27. 6.5.2 Eli Lilly and Company Business Overview
  28. 6.5.3 Eli Lilly and Company Fast-Acting Insulin Analog Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Eli Lilly and Company Fast-Acting Insulin Analog Product Portfolio
  30. 6.5.5 Eli Lilly and Company Recent Developments
  31. 6.6 Gan and Lee Pharmaceuticals
  32. 6.6.1 Gan and Lee Pharmaceuticals Company Information
  33. 6.6.2 Gan and Lee Pharmaceuticals Business Overview
  34. 6.6.3 Gan and Lee Pharmaceuticals Fast-Acting Insulin Analog Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Gan and Lee Pharmaceuticals Fast-Acting Insulin Analog Product Portfolio
  36. 6.6.5 Gan and Lee Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Fast-Acting Insulin Analog Sales by Country
  2. 7.1.1 North America Fast-Acting Insulin Analog Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Fast-Acting Insulin Analog Sales by Country (2021-2026)
  4. 7.1.3 North America Fast-Acting Insulin Analog Sales Forecast by Country (2027-2032)
  5. 7.2 North America Fast-Acting Insulin Analog Market Size by Country
  6. 7.2.1 North America Fast-Acting Insulin Analog Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Fast-Acting Insulin Analog Market Size by Country (2021-2026)
  8. 7.2.3 North America Fast-Acting Insulin Analog Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Fast-Acting Insulin Analog Sales by Country
  2. 8.1.1 Europe Fast-Acting Insulin Analog Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Fast-Acting Insulin Analog Sales by Country (2021-2026)
  4. 8.1.3 Europe Fast-Acting Insulin Analog Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Fast-Acting Insulin Analog Market Size by Country
  6. 8.2.1 Europe Fast-Acting Insulin Analog Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Fast-Acting Insulin Analog Market Size by Country (2021-2026)
  8. 8.2.3 Europe Fast-Acting Insulin Analog Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Fast-Acting Insulin Analog Sales by Country
  2. 9.1.1 Asia-Pacific Fast-Acting Insulin Analog Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Fast-Acting Insulin Analog Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Fast-Acting Insulin Analog Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Fast-Acting Insulin Analog Market Size by Country
  6. 9.2.1 Asia-Pacific Fast-Acting Insulin Analog Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Fast-Acting Insulin Analog Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Fast-Acting Insulin Analog Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Fast-Acting Insulin Analog Sales by Country
  2. 10.1.1 South America Fast-Acting Insulin Analog Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Fast-Acting Insulin Analog Sales by Country (2021-2026)
  4. 10.1.3 South America Fast-Acting Insulin Analog Sales Forecast by Country (2027-2032)
  5. 10.2 South America Fast-Acting Insulin Analog Market Size by Country
  6. 10.2.1 South America Fast-Acting Insulin Analog Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Fast-Acting Insulin Analog Market Size by Country (2021-2026)
  8. 10.2.3 South America Fast-Acting Insulin Analog Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Fast-Acting Insulin Analog Sales by Country
  2. 11.1.1 Middle East and Africa Fast-Acting Insulin Analog Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Fast-Acting Insulin Analog Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Fast-Acting Insulin Analog Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Fast-Acting Insulin Analog Market Size by Country
  6. 11.2.1 Middle East and Africa Fast-Acting Insulin Analog Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Fast-Acting Insulin Analog Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Fast-Acting Insulin Analog Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Fast-Acting Insulin Analog Value Chain Analysis
  2. 12.1.1 Fast-Acting Insulin Analog Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Fast-Acting Insulin Analog Production Mode & Process
  7. 12.2 Fast-Acting Insulin Analog Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Fast-Acting Insulin Analog Distributors
  10. 12.2.3 Fast-Acting Insulin Analog Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst